Retinoic acid receptor β induces terminal differentiation of squamous cell carcinoma lines in the absence of cyclin-dependent kinase inhibitor expression

Cancer Research

Volumn 58, Issue 1, 1998, Pages 142-148

  Crowe, David L ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; DNA FRAGMENT; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR;

ARTICLE; CELL DEATH; CONTROLLED STUDY; DNA TRANSFECTION; DRUG EFFECT; GENE EXPRESSION; GENE TARGETING; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; TUMOR DIFFERENTIATION;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA FRAGMENTATION; DNA, NEOPLASM; GENETIC VECTORS; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM PROTEINS; RECEPTORS, RETINOIC ACID; TUMOR CELLS, CULTURED;

EID: 0031975455     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Fuchs, E. Epidermal differentiation: the bare essentials. J. Cell Biol., 111: 2807-2814, 1990.
2. Fuchs, E., and Byrne, C. The epidermis: rising to the surface. Curr. Opin. Genet. Dev., 4: 725-729, 1994.
3. Lotan, R. Suppression of squamous cell carcinoma growth and differentiation by retinoids. Cancer Res., 54: 1987s-1990s, 1994.
4. Presland, R. B., Kimball, J. R., Kautsky, M. B., Lewis, S. P., Lo, C. Y., and Dale, B. A. Evidence for specific proteolytic cleavage of the N-terminal domain of human profilaggrin during epidermal differentiation. J. Invest. Dermatol., 108: 170-178, 1997.
5. Giminez, I. B., Shin, D. M., Bianchi, A. B., Roop, D. R., Hong, W. K., Conti, C. J., and Slaga, T. J. Changes in keratin expression during 7,12-dimethylbenz[a]anthracene induced hamster cheek pouch carcinogenesis. Cancer Res., 50: 4441-4445, 1990.
6. Zhang, S. Y., Klein-Szanto, A. J. P., Sauter, E. R., Shafarenko, M., Mitsunaga, S., Nobori, T., Carson, D. A., Ridge, J. A., and Goodrow, T. L. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res., 54: 5050-5053, 1994.
7. Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras tumor progression. Genes Dev., 10: 3065-3075, 1996.
8. Reed, A. L., Califano, J., Cairns, P., Westra, W. H., Jones, R. M., Koch, W., Ahrendt, S., Eby, Y., Sewell, D., Nawroz, H., Bartek, J., and Sidransky, D. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res., 56: 3630-3633, 1996.
9. 1 cyclin dependent kinases. Genes Dev., 9, 1149-1163, 1995.
10. Liggett, W. H., Jr., Sewell, D. A., Rocco, J., Ahrendt, S. A., Koch, W., and Sidransky, D. p16 and p16β are potent growth suppressors of head and neck squamous carcinoma cells m vitro. Cancer Res., 56: 4119-4123, 1996.
11. Zou, C. P., Clifford, J. L., Xu, X. C., Sacks, P. G., Chambon, P., Hong, W. K., and Lotan, R. Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA binding proteins, and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines. Cancer Res., 54: 5479-5487, 1994.
12. WAF1/CIP1 gene by retinoic acid receptor. J. Biol. Chem., 271: 31723-31728, 1996.
13. Jetten, A. M., Nervi, C., and Vollberg, T. M. Control of squamous differentiation in tracheobronchial and epidermal epithelial cells: role of retinoids. J. Natl. Cancer Inst. Monogr., 13: 93-100, 1992.
14. Hong, W. K., Endicott, J., Itri, L. M., Doos, W., Batskis, J. G., Bell, R., Fofonoff, S., Byers, R., Atkinson, E. N., Vaughan, C., Toht, B. B., Kramer, A., Dimery, I. W., Skipper, P., and Strong, S. 13-cis-Retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med., 315: 1501-1505, 1986.
15. Hong, W. K., Lippman, S. M., Itri, L. M., Karp, D. D., Lee, J. S., Byers, R. M., Schantz, S. P., Kramer, A. M., Lotan, R., Peters, L. J., Dimery, I. W., Brown, B. W., and Goepfert, H. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N. Engl. J. Med., 323: 795-801, 1990.
16. Lippman, S. M., Benner, S. E., and Hong, W. K. Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis. Cancer Res., 54: 2025s-2028s, 1994.
17. Kastner, P., Mark, M., and Chambon, P. Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell, 83: 859-869, 1995.
18. Leid, M., Kastner, P, and Chambon, P. Multiplicity generates diversity in the retinoic acid signaling pathways. Trends Biochem. Sci., 17: 427-433, 1992.
19. Hu, L., Crowe, D. L., Rheinwald, J. G., Chambon, P., and Gudas, L. J. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma lines. Cancer Res., 51: 3972-2981, 1991.
20. Zhang, X. K., Liu, Y., Lee, M. O., and Pfahl, M. A specific defect in the retinoic acid response associated with human lung cancer cell lines. Cancer Res., 54: 5663-5669, 1994.
21. Kim, Y. H., Dohi, D. F., Han, G. R., Zou, C. P., Oridate, N., Walsh, G. L., Nesbitt, J. C., Xu, X. C., Hong, W. K., Lotan, R., and Kurie, J. M. Retinoid refractoriness occurs during lung carcinogenesis despite functional retinoid receptors. Cancer Res., 55: 5603-5610, 1995.
22. Liu, Y., Lee, M. O., Wang, H. G., Li, Y., Hashimoto, Y., Klaus, M., Reed, J. C., and Zhang, X. Retinoic acid receptor beta mediates the growth inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol. Cell. Biol., 16: 1138-1149, 1996.
23. Smarda, J., Sugarman, J., Glass, C., and Lipsick, J. Retinoic acid receptor α suppresses transformation by v-myb. Mol. Cell. Biol., 15: 2474-2481, 1995.
24. Crowe, D. L. Retinoic acid mediates posttranscriptional regulation of keratin 19 mRNA levels. J. Cell Sci., 106: 183-188, 1993.
25. Astrom, A., Tavakkol, A., Pettersson, U., Cromie, M., Elder, J. T., and Voorhees, J. J. Molecular cloning of two human cellular retinoic acid binding proteins (CRABP). J. Biol. Chem., 266: 17662-17666, 1991.
26. Tyner, A. L., Eichman, M. J., and Fuchs, E. The sequence of a type II keratin gene expressed in human skin: conservation of structure among all intermediate filament genes. Proc. Natl. Acad. Sci. USA. 82: 4683-4687, 1985.
27. Kulesh, D. A., Cecena, G., Darmon, Y. M., Vasseur, M., and Oshima, R. G. Posttranslational regulation of keratins: degradation of mouse and human keratins 18 and 8. Mol. Cell. Biol., 9: 1553-1565, 1989.
28. INK4a in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA. 93: 13742-13747, 1996.
29. Eckert, R. L., and Green, H. Structure and evolution of the human involucrin gene. Cell, 46: 583-589, 1986.
30. Vincenz, C., and Dixit, V. M. Fas-associated death domain protein interleukin-1β-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95-and p55-mediated death signaling. J. Biol. Chem., 272: 6578-6583, 1997.
31. Crowe, D. L., Hu, L., Gudas, L. J., and Rheinwald, J. G. Variable expression of retinoic acid receptor (RAR beta) mRNA in human oral and epidermal keratinocytes: relation to keratin 19 expression and keratinization potential. Differentiation, 48: 199-208, 1991.
32. Robertson, K. A., Emami, B., Mueller, L., and Collins, S. J. Multiple members of the retinoic acid receptor family are capable of mediating the granulocytic differentiation of HL-60 cells. Mol. Cell. Biol., 12: 3743-3749, 1992.
33. Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A., and Dejean, A. Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells. Cell, 76: 345-356, 1994.
34. Van der Berg, B., van der Leede, B. J. M., Kwakkenbox-Isbrucker, L., Salverda, S., de Laat, S. W., and van der Saag, P. T. Retinoic acid resistance of estradiol independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol. Cell. Endocrinol., 91: 149-157, 1993.
35. Swisshelm, K., Ryan, K., Lee, X., Tsou, H. C., Beacocke, M., and Sager, R. Downregulation of retinoic acid receptor β in mammary carcinoma cell lines and its upregulation in senescing normal mammary epithelial cells. Cell Growth Differ., 5: 133-141, 1994.
36. Tontonoz, P., Singer, S., Forman, B. M., Sarraf, P., Fletcher, J. A., Fletcher, C. D. M., Brun, R. P., Mueller, E., Altiok, S., Oppenheim, H., Evans, R. M., and Spiegelman, B. M. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator activated receptor γ and the retinoid X receptor. Proc. Natl. Acad. Sci. USA. 94: 237-241, 1997.
37. El-Deiry, W. S., Takashi, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
38. Kip1) of cyclin dependent kinase 4 activation. Cell, 79: 487-496, 1994.
39. II 28 promotes transcriptional stimulation by activation function 2 of the retinoid X receptors. EMBO J., 15: 3093-3104, 1996.
40. McInerney, E. M., Tsai, M. J., O'Malley, B. W., and Katzenellenbogen, B. S. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. Proc. Natl. Acad. Sci. USA, 93: 10069-10073, 1996.
41. Chakravarti, D., LaMorte, V. J., Nelson, M. C., Nakajima, T., Schulman, I. G., Juguilon, H., Montminy, M., and Evans, R. M. Role of CBP/p300 in nuclear receptor signaling. Nature (Lond.), 383: 99-103, 1996.
42. Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S. C., Heyman, R. A., Rose, D. W., Glass, C. K., and Rosenfeld, M. G. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell, 85: 403-414, 1996.
43. Kurokawa, R., Soderstrom, M., Horlein, A., Halachmi, S., Brown, M., Rosenfeld, M. G., and Glass, C. K. Polarity specific activities of retinoic acid receptors determined by a co-repressor. Nature (Lond.), 377: 451-454, 1995.
44. Chen, J. D., Umesono, K., and Evans, R. M. SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. Proc. Natl. Acad. Sci. USA, 93: 7567-7571, 1996.
45. Casanova, J., Helmer, E., Selmi-Ruby, S., Qi, J. S., Au Fliegner, M., Desai-Yajnik, V., Koudinova, N., Yarm, F., Raaka, B. M., and Samuels, H. H. Functional evidence for ligand dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor. Mol. Cell. Biol., 14: 5756-5765, 1994.